DK1387693T3 - Saponininaktiveret mykoplasmavaccine - Google Patents
Saponininaktiveret mykoplasmavaccineInfo
- Publication number
- DK1387693T3 DK1387693T3 DK02720307T DK02720307T DK1387693T3 DK 1387693 T3 DK1387693 T3 DK 1387693T3 DK 02720307 T DK02720307 T DK 02720307T DK 02720307 T DK02720307 T DK 02720307T DK 1387693 T3 DK1387693 T3 DK 1387693T3
- Authority
- DK
- Denmark
- Prior art keywords
- saponin
- mycoplasma
- inactivated mycoplasma
- mycoplasma vaccine
- strain
- Prior art date
Links
- 241000204031 Mycoplasma Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001138504 Mycoplasma bovis Species 0.000 abstract 1
- 241000178641 Mycoplasma mycoides subsp. mycoides SC Species 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0110851.3A GB0110851D0 (en) | 2001-05-03 | 2001-05-03 | Vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1387693T3 true DK1387693T3 (da) | 2006-11-13 |
Family
ID=9913953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02720307T DK1387693T3 (da) | 2001-05-03 | 2002-05-03 | Saponininaktiveret mykoplasmavaccine |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20040170652A1 (es) |
| EP (1) | EP1387693B1 (es) |
| AT (1) | ATE335505T1 (es) |
| CA (1) | CA2445997A1 (es) |
| CY (1) | CY1107538T1 (es) |
| DE (1) | DE60213785T2 (es) |
| DK (1) | DK1387693T3 (es) |
| ES (1) | ES2269672T3 (es) |
| GB (1) | GB0110851D0 (es) |
| MX (1) | MXPA03010053A (es) |
| PT (1) | PT1387693E (es) |
| WO (1) | WO2002089838A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| US20070009545A1 (en) * | 2005-07-07 | 2007-01-11 | Joachim Frey | Mycoplasma subunit vaccine |
| CN101721694B (zh) * | 2009-11-07 | 2013-01-30 | 中国农业科学院兰州兽医研究所 | 山羊支原体肺炎二联灭活疫苗及其制备方法 |
| SI3334454T1 (sl) | 2015-08-14 | 2023-02-28 | Zoetis Services Llc | Sestave mycoplasma bovis |
| CN110551653A (zh) * | 2019-09-04 | 2019-12-10 | 中国农业科学院兰州兽医研究所 | 一种无血清制备牛支原体抗原的方法 |
| CN110551634A (zh) * | 2019-09-04 | 2019-12-10 | 中国农业科学院兰州兽医研究所 | 一种山羊支原体山羊肺炎亚种分离培养方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5540568B2 (es) * | 1972-10-05 | 1980-10-18 | ||
| GB9108682D0 (en) * | 1991-04-23 | 1991-06-12 | Wellcome Found | Production of vaccines |
| WO1995022314A1 (en) * | 1994-02-18 | 1995-08-24 | Innovac Co. | Inoculation of animals with dried, pelleted biological materials |
| EP1229929A2 (en) * | 1999-11-08 | 2002-08-14 | Biomune | VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2001
- 2001-05-03 GB GBGB0110851.3A patent/GB0110851D0/en not_active Ceased
-
2002
- 2002-05-03 MX MXPA03010053A patent/MXPA03010053A/es active IP Right Grant
- 2002-05-03 PT PT02720307T patent/PT1387693E/pt unknown
- 2002-05-03 ES ES02720307T patent/ES2269672T3/es not_active Expired - Lifetime
- 2002-05-03 AT AT02720307T patent/ATE335505T1/de not_active IP Right Cessation
- 2002-05-03 EP EP02720307A patent/EP1387693B1/en not_active Expired - Lifetime
- 2002-05-03 CA CA002445997A patent/CA2445997A1/en not_active Abandoned
- 2002-05-03 US US10/476,508 patent/US20040170652A1/en not_active Abandoned
- 2002-05-03 DE DE60213785T patent/DE60213785T2/de not_active Expired - Lifetime
- 2002-05-03 WO PCT/GB2002/002062 patent/WO2002089838A1/en active IP Right Grant
- 2002-05-03 DK DK02720307T patent/DK1387693T3/da active
-
2006
- 2006-10-24 CY CY20061101522T patent/CY1107538T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1387693E (pt) | 2006-12-29 |
| EP1387693B1 (en) | 2006-08-09 |
| WO2002089838A1 (en) | 2002-11-14 |
| EP1387693A1 (en) | 2004-02-11 |
| CA2445997A1 (en) | 2002-11-14 |
| US20040170652A1 (en) | 2004-09-02 |
| GB0110851D0 (en) | 2001-06-27 |
| MXPA03010053A (es) | 2004-03-09 |
| DE60213785D1 (de) | 2006-09-21 |
| ATE335505T1 (de) | 2006-09-15 |
| ES2269672T3 (es) | 2007-04-01 |
| CY1107538T1 (el) | 2013-03-13 |
| DE60213785T2 (de) | 2007-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021550318A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| MY192183A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof | |
| PH12017501898A1 (en) | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | |
| BR112018007812A2 (pt) | polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica. | |
| MX2019008564A (es) | Composiciones inmunogenicas para su uso en vacunas neumococicas. | |
| AR041880A1 (es) | Composicion inmunogena | |
| TW200719910A (en) | C. perfringens alpha toxoid vaccine | |
| UY26783A1 (es) | Antígenos de estreptococo. | |
| DK1326633T3 (da) | Sammensætning omfattende immunogene mikropartikler | |
| MX2020008454A (es) | Composicion inmunogenica que comprende antigenos estafilococicos. | |
| NZ591950A (en) | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition | |
| DOP2024000040A (es) | Vacunas para vhb y métodos de tratamiento de vhb | |
| UA98506C2 (en) | Attenuated mycoplasma gallisepticum strains | |
| PH12021550484A1 (en) | Immunological adjuvant and vaccine composition including sting agonist | |
| CY1107538T1 (el) | Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη | |
| BRPI0608310A2 (pt) | uso de um poxvìrus modificado para a indução rápida de imunidade contra um poxvìrus ou outros agentes infecciosos | |
| MX2018012270A (es) | Novedosas formulaciones de vacuna neumococica. | |
| DE60135318D1 (de) | Rekombinante bcg-impfstoffe gegen intrazelluläre pathogene und anwendungsverfahren | |
| BR112023021812A2 (pt) | Composição vacinal adjuvantada e métodos | |
| MX2021015155A (es) | Polisacaridos de ramnosa. | |
| AR010568A1 (es) | Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori | |
| UA132124U (uk) | Вакцина проти лептоспірозу м'ясоїдних бівалентна | |
| MX2022001937A (es) | Composicion inmunogenica. | |
| MX2022015860A (es) | Inmunizacion bacteriana que utiliza una vacuna con nanoparticulas. | |
| MX2022000525A (es) | Vacunas contra la ehrlichia y composiciones inmunogenicas. |